Octopus Biosafety Statistics
Total Valuation
EPA:MLOCT has a market cap or net worth of EUR 47.04 million. The enterprise value is 47.56 million.
| Market Cap | 47.04M | 
| Enterprise Value | 47.56M | 
Important Dates
The last earnings date was Friday, June 6, 2025.
| Earnings Date | Jun 6, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
EPA:MLOCT has 127.13 million shares outstanding. The number of shares has increased by 269.15% in one year.
| Current Share Class | 127.13M | 
| Shares Outstanding | 127.13M | 
| Shares Change (YoY) | +269.15% | 
| Shares Change (QoQ) | n/a | 
| Owned by Insiders (%) | n/a | 
| Owned by Institutions (%) | n/a | 
| Float | n/a | 
Valuation Ratios
| PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | 122.14 | 
| PB Ratio | -71.71 | 
| P/TBV Ratio | n/a | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
Enterprise Valuation
| EV / Earnings | -72.16 | 
| EV / Sales | 123.50 | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
The company has a current ratio of 0.32
| Current Ratio | 0.32 | 
| Quick Ratio | 0.30 | 
| Debt / Equity | n/a | 
| Debt / EBITDA | n/a | 
| Debt / FCF | n/a | 
| Interest Coverage | -684.78 | 
Financial Efficiency
| Return on Equity (ROE) | n/a | 
| Return on Assets (ROA) | -83.06% | 
| Return on Invested Capital (ROIC) | -423.18% | 
| Return on Capital Employed (ROCE) | 170.42% | 
| Revenue Per Employee | 64,186 | 
| Profits Per Employee | -109,851 | 
| Employee Count | 6 | 
| Asset Turnover | 0.61 | 
| Inventory Turnover | 20.57 | 
Taxes
| Income Tax | -209,065 | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
The stock price has increased by +134.57% in the last 52 weeks. The beta is -0.10, so EPA:MLOCT's price volatility has been lower than the market average.
| Beta (5Y) | -0.10 | 
| 52-Week Price Change | +134.57% | 
| 50-Day Moving Average | 0.27 | 
| 200-Day Moving Average | 0.22 | 
| Relative Strength Index (RSI) | 73.68 | 
| Average Volume (20 Days) | 5,042 | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | n/a | 
Income Statement
In the last 12 months, EPA:MLOCT had revenue of EUR 385,114 and -659,106 in losses. Loss per share was -0.04.
| Revenue | 385,114 | 
| Gross Profit | -336,293 | 
| Operating Income | -837,481 | 
| Pretax Income | -868,171 | 
| Net Income | -659,106 | 
| EBITDA | -154,741 | 
| EBIT | -837,481 | 
| Loss Per Share | -0.04 | 
Balance Sheet
The company has 22,872 in cash and 546,838 in debt, giving a net cash position of -523,966 or -0.00 per share.
| Cash & Cash Equivalents | 22,872 | 
| Total Debt | 546,838 | 
| Net Cash | -523,966 | 
| Net Cash Per Share | -0.00 | 
| Equity (Book Value) | -655,967 | 
| Book Value Per Share | -0.04 | 
| Working Capital | -670,927 | 
Cash Flow
| Operating Cash Flow | n/a | 
| Capital Expenditures | n/a | 
| Free Cash Flow | n/a | 
| FCF Per Share | n/a | 
Margins
Gross margin is -87.32%, with operating and profit margins of -217.46% and -171.15%.
| Gross Margin | -87.32% | 
| Operating Margin | -217.46% | 
| Pretax Margin | -225.43% | 
| Profit Margin | -171.15% | 
| EBITDA Margin | -40.18% | 
| EBIT Margin | -217.46% | 
| FCF Margin | n/a | 
Dividends & Yields
EPA:MLOCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -269.15% | 
| Shareholder Yield | -269.15% | 
| Earnings Yield | -1.40% | 
| FCF Yield | n/a | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
EPA:MLOCT has an Altman Z-Score of -29.35 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -29.35 | 
| Piotroski F-Score | 2 |